Skip to main content

Atrium C-Qur Hernia Patch Lawsuit Filed in Tennessee

Atrium C-Qur Hernia Patch Lawsuit Filed in Tennessee

Atrium C-Qur Hernia Patch Lawsuit Filed in Tennessee

Introduction

A woman from Tennessee has filed a lawsuit in the U.S. District Court, District of New Jersey, against Atrium Medical Corporation, Getinge AB, and Maquet Cardiovascular US Sales, LLC, over complications she faced after being implanted with Atrium C-Qur V-Patch that she received to treat an incarcerated ventral hernia. She now seeks compensation for injuries and complications for the same.

The plaintiffs involved in hernia patch lawsuits allege that Atrium knew or should have known about problems with the C-Qur V-Patch, but withheld information from consumers and the medical community. And that they quietly removed certain products from the market rather than issuing a formal Atrium C-Qur mesh recall. In December 2016, all Atrium C-Qur lawsuits were consolidated before U.S. District Judge Landya McCafferty in the District of New Hampshire, for coordinated pretrial proceedings. Judge McCafferty is expected to schedule a series of early “bellwether” trials.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!